skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

What benchmarks are you using? Do you know how your development programs compare to your competitors? Do you trust that your decisions are being made based on sound data?


Drill deeper into industry-standard data using peer-reviewed methodology to gain insights you can bank on. Pharmapremia can bring confidence to the accuracy of your benchmarks of internal and external R&D candidate’s approval rates and potential development timelines - leading to informed decisions regarding pipeline prioritization, partnerships and acquisitions.


Watch our video to find out more...



  • ターゲット市場の実像をつかむ, Biomedtracker: 開発中医薬品をFDA承認確率で評価, Pharmaprem...

    2019 Q3 Outlook Webinar

    By Hardik Patel

    Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. 

    Topics $name Infectious Diseases

  • Pharmapremia

    Cancer Treatment is HARD!

    Drug development – it’s an area rife with risk, but with great risk often comes great rewards. An area notoriously prone to failure is oncology, and nowhere is accurate risk assessment more critical. Developing Cancer Treatments is HARD! But is everyone bad at it? is a view into this failure-prone area from Pharmapremia.

    Topics Cancer

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, ターゲット市場の実像をつかむ, Pharmaprem...

    Pharma Quiz

    Test your Pharma knowledge!

    Topics Diseases Approvals

  • Pharmapremia

    Oncology Success Rates Webinar Recording

    21 Jul 2017

    Presented by: Robert Jeng, Senior Scientific Analyst, Will Akie, Product Manager for Pharmapremia, and Ellen Moore of Pharma Consulting.

    Topics Cancer